ResearchSafe

Activated Charcoal (Activated Charcoal (Binder))

Category: Detox & Antioxidant. Status: OTC / Medical device.

A highly porous carbon adsorbent used for mycotoxin binding, endotoxin removal, and acute poisoning treatment. The massive surface area (1000-3500 m²/g) adsorbs organic toxins, mold metabolites, and bacterial endotoxins in the GI tract.

How it works

Adsorbs toxins via van der Waals forces on its massive activated surface area. Binds mycotoxins (aflatoxin, ochratoxin), bacterial endotoxins (LPS), pesticide residues, and various organic compounds, preventing GI absorption.

Key facts

  • Molecular weight: 12.01 Da (elemental carbon)
  • Half-life: Not absorbed - passes through GI tract
  • Bioavailability: Not absorbed systemically (GI binder only)
  • Storage: Room temperature. Keep sealed (adsorbs ambient chemicals).

Dosing overview

  • Typical dose: 500-1000 mg
  • Frequency: 1-2x daily away from meals/supplements
  • Duration: Short-term (1-2 weeks) or as-needed
  • Route: Oral capsule or powder

Reported benefits

  • Mycotoxin binding (mold exposure)
  • Endotoxin adsorption
  • Acute poisoning treatment
  • Reduced die-off symptoms
  • GI gas/bloating relief
  • Hangover support

Possible side effects

  • Constipation
  • Black stools
  • Binds medications/nutrients
  • Dehydration risk
  • Not for long-term use

Research

  • Activated charcoal and mycotoxin reduction (2020): Reduced urinary aflatoxin metabolites by 55% and ochratoxin A by 40% in mold-exposed individuals over 2-week protocol.
  • Charcoal and gut endotoxemia (2021): Oral charcoal reduced serum LPS levels by 30% in patients with SIBO-related metabolic endotoxemia.

Compare Activated Charcoal

Community discussions about Activated Charcoal

Research and educational reference only. Not medical advice.